CrushSCI.com
Journal Selection & Manuscript Polishing Services
Expert Opinion on Drug Discovery journal cover Medicine
Back to journal directory

Review Cycle Records

Expert Opinion on Drug Discovery

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
64.5Average days
62Median days
18Fastest days
110Longest days
1102025 publications

Paper Review Records

All Paper Review Records

13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

41 days

Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10–2474 and the challenges ahead

AuthorsAlessia Catalano; Filomena Fezza; Andrea Duranti; Maria Maddalena Cavalluzzi; Giovanni Lentini; Giuseppe Felice Mangiatordi; Marco Bruno Luigi Rocchi; Mauro Maccarrone

Affiliations1. University of Bari Aldo Moro; 2. University of Rome “Tor Vergata”; 3. University of Urbino Carlo Bo; 4. National Research Council of Italy; 5. University of L’Aquila; 6. Santa Lucia IRCCS

Source PDF DOI Publisher page
91 days

A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)

AuthorsLuis Adrián De Jesús-González; Alan Orlando Santos-Mena; Carlos Noé Farfán-Morales; Moisés León-Juárez; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Daniel Cordero-Rivera; Selvin Noé Palacios-Rápalo; Flor Itzel Lira-Hernández; Rosa María Del Ángel

Affiliations1. Instituto Mexicano del Seguro Social; 2. Center for Research and Advanced Studies (CIN VESTAV-IPN); 3. Unidad Cuajimalpa; 4. Instituto Nacional de Perinatología “Isidro Espinosa de los Reyes”; 5. Instituto Mexicano del Seguro Social (IMSS); 6. Universidad Veracruzana (UV); 7. Universidad Autónoma de Sinaloa (UAS); 8. Instituto Politécnico Nacional (IPN); 9. Institut Pasteur, Université Paris Cité

Source PDF DOI Publisher page
95 days

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications

AuthorsMichail Papadourakis; Evangelia Efraimia Amaxopoulou; Minos-Timotheos Matsoukas

Affiliations1. Cloudpharm PC; 2. University of West Attica

Source PDF DOI Publisher page
42 days

Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets

AuthorsJiahua Chen; Trent Quist; Ronabelle Fang; Henry Thanh Nguyen; Maria-Eirini Pandelia

Affiliations1. Brandeis University

Source PDF DOI Publisher page
43 days

Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?

AuthorsAndrea Hinas; Christian G. Riedel

Affiliations1. Stockholm University; 2. Karolinska Institute

Source PDF DOI Publisher page
110 days

An overview of the current animal models of Marburg virus disease for countermeasure development

AuthorsTakeshi Saito; Junki Maruyama; Ayato Takada

Affiliations1. The University of Texas Medical Branch; 2. Hokkaido University; 3. University of Zambia

Source PDF DOI Publisher page
61 days

Targeting ferroptosis in lung cancer: emerging strategies and drug discovery opportunities

AuthorsQianyi Chen; Hao Liu; Cien Sun; Ziming Wang; William C. Cho; Jianfei Shen

Affiliations1. Taizhou Hospital of Zhejiang Province Affiliated to Zhejiang University; 2. Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University; 3. Queen Elizabeth Hospital

Source PDF DOI Publisher page
62 days

Can Artificial intelligence meaningfully shorten drug discovery timelines? Current evidence, roadblocks and future directions

AuthorsJuan Luis Fernández-Martínez

Affiliations1. University of Oviedo

Source PDF DOI Publisher page
18 days

Advancing polypharmacology-based drug discovery using deep generative models

AuthorsJürgen Bajorath

Affiliations1. Lamarr Institute for Machine Learning and Artificial Intelligence, Rheinische Friedrich-Wilhelms-Universität

Source PDF DOI Publisher page
62 days

Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights

AuthorsHa-Yeon Song

Affiliations1. Korea Atomic Energy Research Institute (KAERI)

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.